The CHADS2 score may be a useful predictor of prognosis in chronic limb-threatening ischemia patients after endovascular intervention with and without AF Article Swipe
N. Ito
,
Daisuke Kanda
,
Dai Fukumoto
,
Kenta Ohmure
,
Yoshiyuki Ikeda
,
Mitsuru Ohishi
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1093/eurheartj/ehad655.2054
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1093/eurheartj/ehad655.2054
Background Chronic limb-threatening ischemia (CLTI) represents the end-stage manifestation of peripheral artery disease. Recently, the Society for Vascular Surgery established the Wound, Ischemia, and foot Infection (WIfI) classification system, focusing on disease severity rather than arterial lesion characteristics. The WIfI clinical stage has been thought to have a prognostic value in CLTI patients. While the CHADS2 score is well known to predicts ischemic stroke/transient ischemic attack in atrial fibrillation (AF) patients, the clinical significance of the CHADS2 score remains unclear in CTLI patients with and without AF. Purpose The purpose of this study was to investigate the patient’s clinical factors including WIfI clinical stage and CHADS2 score, and mortality of CLTI patients undergoing endovascular intervention. Methods This retrospective study investigated 200 consecutive CLTI patients and we individually assessed WIfI clinical stage and CHADS2 score. We then compared mortality after endovascular intervention between a WIfI stage 1, 2 group and a stage 3, 4 group, and investigated association between baseline characteristics and WIfI clinical stage 1, 2 group and a stage 3, 4 group. Results Among 200 patients, 123 patients (62%) showed WIfI stage 1 or 2, and the remaining 77 patients (38%) had WIfI stage 3 or 4. Age was significantly higher in the WIfI stage 3, 4 group [median 75, interquartile range (IQR) 68–82] compared with the WIfI stage 1, 2 group (median 70, IQR 63–79, p=0.004). The rate of AF patients was no difference between WIfI stage 1, 2 group and a stage 3, 4 group (59% vs 41%, p=0.84). CHADS2 score was significantly higher in the WIfI stage 3, 4 group than in the WIfI stage 1, 2 group (median 3, IQR 2–3 vs. median 2, IQR 1–2, p=0.013). Median duration of follow-up was 966 days (IQR, 540–1268 days). Forty patients (20%) died after endovascular intervention. Incidences of all-cause death were higher in the WIfI stage 3, 4 group than in the WIfI stage 1, 2 group (27% vs. 15%, p=0.047). Kaplan–Meier analysis showed a significantly lower survival rate in the WIfI stage 3, 4 group than in the WIfI stage 1, 2 group (p=0.002 by log-rank test). Cox proportional hazard univariate analysis revealed that WIfI stage 3, 4 group [Hazard ratio (HR);2.62, 95% confidence interval (CI):1.39–4.91, p=0.003], CHADS2 score (HR;1.42, 95%CI:1.08–1.82, p=0.008) were correlated to all-cause death. Multivariate analysis using relevant factors from univariate analysis showed WIfI stage 3, 4 group (HR;2.18, 95% CI:1.04–4.16, p=0.031) and CHADS2 score (HR:1.34, 95% CI:1.02–1.73, p=0.019) were significantly associated with all-cause death. A comparison of P-value for interaction of WIfI stage 3, 4 group and CHADS2 score was p=0.17. Conclusion CHADS2 score may be a crucial independent predictor for incidence of all-cause death in CLTI patients undergoing endovascular intervention with and without AF.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1093/eurheartj/ehad655.2054
- https://academic.oup.com/eurheartj/article-pdf/44/Supplement_2/ehad655.2054/53601832/ehad655.2054.pdf
- OA Status
- bronze
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4388915283
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4388915283Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1093/eurheartj/ehad655.2054Digital Object Identifier
- Title
-
The CHADS2 score may be a useful predictor of prognosis in chronic limb-threatening ischemia patients after endovascular intervention with and without AFWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-11-01Full publication date if available
- Authors
-
N. Ito, Daisuke Kanda, Dai Fukumoto, Kenta Ohmure, Yoshiyuki Ikeda, Mitsuru OhishiList of authors in order
- Landing page
-
https://doi.org/10.1093/eurheartj/ehad655.2054Publisher landing page
- PDF URL
-
https://academic.oup.com/eurheartj/article-pdf/44/Supplement_2/ehad655.2054/53601832/ehad655.2054.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://academic.oup.com/eurheartj/article-pdf/44/Supplement_2/ehad655.2054/53601832/ehad655.2054.pdfDirect OA link when available
- Concepts
-
Medicine, Interquartile range, Stage (stratigraphy), Atrial fibrillation, Internal medicine, Stroke (engine), Cardiology, Clinical significance, Coronary artery disease, Ischemic stroke, Ischemia, Mechanical engineering, Biology, Engineering, PaleontologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4388915283 |
|---|---|
| doi | https://doi.org/10.1093/eurheartj/ehad655.2054 |
| ids.doi | https://doi.org/10.1093/eurheartj/ehad655.2054 |
| ids.openalex | https://openalex.org/W4388915283 |
| fwci | 0.0 |
| type | article |
| title | The CHADS2 score may be a useful predictor of prognosis in chronic limb-threatening ischemia patients after endovascular intervention with and without AF |
| biblio.issue | Supplement_2 |
| biblio.volume | 44 |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10926 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9995999932289124 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2746 |
| topics[0].subfield.display_name | Surgery |
| topics[0].display_name | Peripheral Artery Disease Management |
| topics[1].id | https://openalex.org/T10227 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9901999831199646 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2713 |
| topics[1].subfield.display_name | Epidemiology |
| topics[1].display_name | Acute Ischemic Stroke Management |
| topics[2].id | https://openalex.org/T11227 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9825999736785889 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2712 |
| topics[2].subfield.display_name | Endocrinology, Diabetes and Metabolism |
| topics[2].display_name | Diabetic Foot Ulcer Assessment and Management |
| is_xpac | False |
| apc_list.value | 4238 |
| apc_list.currency | EUR |
| apc_list.value_usd | 4570 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9530999064445496 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C119060515 |
| concepts[1].level | 2 |
| concepts[1].score | 0.889559268951416 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1916617 |
| concepts[1].display_name | Interquartile range |
| concepts[2].id | https://openalex.org/C146357865 |
| concepts[2].level | 2 |
| concepts[2].score | 0.7352234125137329 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1123245 |
| concepts[2].display_name | Stage (stratigraphy) |
| concepts[3].id | https://openalex.org/C2779161974 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5863697528839111 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q815819 |
| concepts[3].display_name | Atrial fibrillation |
| concepts[4].id | https://openalex.org/C126322002 |
| concepts[4].level | 1 |
| concepts[4].score | 0.57878577709198 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[4].display_name | Internal medicine |
| concepts[5].id | https://openalex.org/C2780645631 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5727720260620117 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q671554 |
| concepts[5].display_name | Stroke (engine) |
| concepts[6].id | https://openalex.org/C164705383 |
| concepts[6].level | 1 |
| concepts[6].score | 0.5428320169448853 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q10379 |
| concepts[6].display_name | Cardiology |
| concepts[7].id | https://openalex.org/C63363279 |
| concepts[7].level | 2 |
| concepts[7].score | 0.515335738658905 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q5133848 |
| concepts[7].display_name | Clinical significance |
| concepts[8].id | https://openalex.org/C2778213512 |
| concepts[8].level | 2 |
| concepts[8].score | 0.47640812397003174 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q844935 |
| concepts[8].display_name | Coronary artery disease |
| concepts[9].id | https://openalex.org/C3020199598 |
| concepts[9].level | 3 |
| concepts[9].score | 0.4711683392524719 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q12202 |
| concepts[9].display_name | Ischemic stroke |
| concepts[10].id | https://openalex.org/C541997718 |
| concepts[10].level | 2 |
| concepts[10].score | 0.450501024723053 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q188151 |
| concepts[10].display_name | Ischemia |
| concepts[11].id | https://openalex.org/C78519656 |
| concepts[11].level | 1 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q101333 |
| concepts[11].display_name | Mechanical engineering |
| concepts[12].id | https://openalex.org/C86803240 |
| concepts[12].level | 0 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[12].display_name | Biology |
| concepts[13].id | https://openalex.org/C127413603 |
| concepts[13].level | 0 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q11023 |
| concepts[13].display_name | Engineering |
| concepts[14].id | https://openalex.org/C151730666 |
| concepts[14].level | 1 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7205 |
| concepts[14].display_name | Paleontology |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9530999064445496 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/interquartile-range |
| keywords[1].score | 0.889559268951416 |
| keywords[1].display_name | Interquartile range |
| keywords[2].id | https://openalex.org/keywords/stage |
| keywords[2].score | 0.7352234125137329 |
| keywords[2].display_name | Stage (stratigraphy) |
| keywords[3].id | https://openalex.org/keywords/atrial-fibrillation |
| keywords[3].score | 0.5863697528839111 |
| keywords[3].display_name | Atrial fibrillation |
| keywords[4].id | https://openalex.org/keywords/internal-medicine |
| keywords[4].score | 0.57878577709198 |
| keywords[4].display_name | Internal medicine |
| keywords[5].id | https://openalex.org/keywords/stroke |
| keywords[5].score | 0.5727720260620117 |
| keywords[5].display_name | Stroke (engine) |
| keywords[6].id | https://openalex.org/keywords/cardiology |
| keywords[6].score | 0.5428320169448853 |
| keywords[6].display_name | Cardiology |
| keywords[7].id | https://openalex.org/keywords/clinical-significance |
| keywords[7].score | 0.515335738658905 |
| keywords[7].display_name | Clinical significance |
| keywords[8].id | https://openalex.org/keywords/coronary-artery-disease |
| keywords[8].score | 0.47640812397003174 |
| keywords[8].display_name | Coronary artery disease |
| keywords[9].id | https://openalex.org/keywords/ischemic-stroke |
| keywords[9].score | 0.4711683392524719 |
| keywords[9].display_name | Ischemic stroke |
| keywords[10].id | https://openalex.org/keywords/ischemia |
| keywords[10].score | 0.450501024723053 |
| keywords[10].display_name | Ischemia |
| language | en |
| locations[0].id | doi:10.1093/eurheartj/ehad655.2054 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S181568219 |
| locations[0].source.issn | 0195-668X, 1522-9645 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0195-668X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | European Heart Journal |
| locations[0].source.host_organization | https://openalex.org/P4310311648 |
| locations[0].source.host_organization_name | Oxford University Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310311648, https://openalex.org/P4310311647 |
| locations[0].source.host_organization_lineage_names | Oxford University Press, University of Oxford |
| locations[0].license | |
| locations[0].pdf_url | https://academic.oup.com/eurheartj/article-pdf/44/Supplement_2/ehad655.2054/53601832/ehad655.2054.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | European Heart Journal |
| locations[0].landing_page_url | https://doi.org/10.1093/eurheartj/ehad655.2054 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5005136550 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-4704-4137 |
| authorships[0].author.display_name | N. Ito |
| authorships[0].countries | JP |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I107139324 |
| authorships[0].affiliations[0].raw_affiliation_string | Kagoshima University , Kagoshima , Japan |
| authorships[0].institutions[0].id | https://openalex.org/I107139324 |
| authorships[0].institutions[0].ror | https://ror.org/03ss88z23 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I107139324 |
| authorships[0].institutions[0].country_code | JP |
| authorships[0].institutions[0].display_name | Kagoshima University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | N Ito |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Kagoshima University , Kagoshima , Japan |
| authorships[1].author.id | https://openalex.org/A5066119756 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-5314-5295 |
| authorships[1].author.display_name | Daisuke Kanda |
| authorships[1].countries | JP |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I107139324 |
| authorships[1].affiliations[0].raw_affiliation_string | Kagoshima University , Kagoshima , Japan |
| authorships[1].institutions[0].id | https://openalex.org/I107139324 |
| authorships[1].institutions[0].ror | https://ror.org/03ss88z23 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I107139324 |
| authorships[1].institutions[0].country_code | JP |
| authorships[1].institutions[0].display_name | Kagoshima University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | D Kanda |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Kagoshima University , Kagoshima , Japan |
| authorships[2].author.id | https://openalex.org/A5000257171 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Dai Fukumoto |
| authorships[2].countries | JP |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I107139324 |
| authorships[2].affiliations[0].raw_affiliation_string | Kagoshima University , Kagoshima , Japan |
| authorships[2].institutions[0].id | https://openalex.org/I107139324 |
| authorships[2].institutions[0].ror | https://ror.org/03ss88z23 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I107139324 |
| authorships[2].institutions[0].country_code | JP |
| authorships[2].institutions[0].display_name | Kagoshima University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | D Fukumoto |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Kagoshima University , Kagoshima , Japan |
| authorships[3].author.id | https://openalex.org/A5048002781 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-8741-3876 |
| authorships[3].author.display_name | Kenta Ohmure |
| authorships[3].countries | JP |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I107139324 |
| authorships[3].affiliations[0].raw_affiliation_string | Kagoshima University , Kagoshima , Japan |
| authorships[3].institutions[0].id | https://openalex.org/I107139324 |
| authorships[3].institutions[0].ror | https://ror.org/03ss88z23 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I107139324 |
| authorships[3].institutions[0].country_code | JP |
| authorships[3].institutions[0].display_name | Kagoshima University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | K Ohmure |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Kagoshima University , Kagoshima , Japan |
| authorships[4].author.id | https://openalex.org/A5032656014 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-5452-1504 |
| authorships[4].author.display_name | Yoshiyuki Ikeda |
| authorships[4].countries | JP |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I107139324 |
| authorships[4].affiliations[0].raw_affiliation_string | Kagoshima University , Kagoshima , Japan |
| authorships[4].institutions[0].id | https://openalex.org/I107139324 |
| authorships[4].institutions[0].ror | https://ror.org/03ss88z23 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I107139324 |
| authorships[4].institutions[0].country_code | JP |
| authorships[4].institutions[0].display_name | Kagoshima University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Y Ikeda |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Kagoshima University , Kagoshima , Japan |
| authorships[5].author.id | https://openalex.org/A5110793230 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Mitsuru Ohishi |
| authorships[5].countries | JP |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I107139324 |
| authorships[5].affiliations[0].raw_affiliation_string | Kagoshima University , Kagoshima , Japan |
| authorships[5].institutions[0].id | https://openalex.org/I107139324 |
| authorships[5].institutions[0].ror | https://ror.org/03ss88z23 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I107139324 |
| authorships[5].institutions[0].country_code | JP |
| authorships[5].institutions[0].display_name | Kagoshima University |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | M Ohishi |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Kagoshima University , Kagoshima , Japan |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://academic.oup.com/eurheartj/article-pdf/44/Supplement_2/ehad655.2054/53601832/ehad655.2054.pdf |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | The CHADS2 score may be a useful predictor of prognosis in chronic limb-threatening ischemia patients after endovascular intervention with and without AF |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10926 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9995999932289124 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2746 |
| primary_topic.subfield.display_name | Surgery |
| primary_topic.display_name | Peripheral Artery Disease Management |
| related_works | https://openalex.org/W2487490720, https://openalex.org/W2793077515, https://openalex.org/W4292573045, https://openalex.org/W2126365059, https://openalex.org/W4386009577, https://openalex.org/W2981615369, https://openalex.org/W3130621552, https://openalex.org/W3123830081, https://openalex.org/W2945373490, https://openalex.org/W2383747032 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1093/eurheartj/ehad655.2054 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S181568219 |
| best_oa_location.source.issn | 0195-668X, 1522-9645 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0195-668X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | European Heart Journal |
| best_oa_location.source.host_organization | https://openalex.org/P4310311648 |
| best_oa_location.source.host_organization_name | Oxford University Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310311648, https://openalex.org/P4310311647 |
| best_oa_location.source.host_organization_lineage_names | Oxford University Press, University of Oxford |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://academic.oup.com/eurheartj/article-pdf/44/Supplement_2/ehad655.2054/53601832/ehad655.2054.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | European Heart Journal |
| best_oa_location.landing_page_url | https://doi.org/10.1093/eurheartj/ehad655.2054 |
| primary_location.id | doi:10.1093/eurheartj/ehad655.2054 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S181568219 |
| primary_location.source.issn | 0195-668X, 1522-9645 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0195-668X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | European Heart Journal |
| primary_location.source.host_organization | https://openalex.org/P4310311648 |
| primary_location.source.host_organization_name | Oxford University Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310311648, https://openalex.org/P4310311647 |
| primary_location.source.host_organization_lineage_names | Oxford University Press, University of Oxford |
| primary_location.license | |
| primary_location.pdf_url | https://academic.oup.com/eurheartj/article-pdf/44/Supplement_2/ehad655.2054/53601832/ehad655.2054.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | European Heart Journal |
| primary_location.landing_page_url | https://doi.org/10.1093/eurheartj/ehad655.2054 |
| publication_date | 2023-11-01 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.1 | 184 |
| abstract_inverted_index.2 | 147, 166, 222, 241, 271, 319, 346 |
| abstract_inverted_index.3 | 196 |
| abstract_inverted_index.4 | 153, 172, 208, 247, 263, 311, 338, 362, 394, 423 |
| abstract_inverted_index.A | 413 |
| abstract_inverted_index.a | 48, 143, 150, 169, 244, 328, 435 |
| abstract_inverted_index.1, | 146, 165, 221, 240, 270, 318, 345 |
| abstract_inverted_index.2, | 186, 279 |
| abstract_inverted_index.3, | 152, 171, 207, 246, 262, 274, 310, 337, 361, 393, 422 |
| abstract_inverted_index.4. | 198 |
| abstract_inverted_index.77 | 190 |
| abstract_inverted_index.AF | 232 |
| abstract_inverted_index.We | 135 |
| abstract_inverted_index.be | 434 |
| abstract_inverted_index.by | 349 |
| abstract_inverted_index.in | 51, 67, 81, 203, 258, 266, 306, 314, 333, 341, 444 |
| abstract_inverted_index.is | 58 |
| abstract_inverted_index.no | 235 |
| abstract_inverted_index.of | 10, 75, 91, 110, 231, 285, 301, 415, 419, 441 |
| abstract_inverted_index.on | 31 |
| abstract_inverted_index.or | 185, 197 |
| abstract_inverted_index.to | 46, 61, 95, 379 |
| abstract_inverted_index.vs | 250 |
| abstract_inverted_index.we | 126 |
| abstract_inverted_index.123 | 178 |
| abstract_inverted_index.200 | 121, 176 |
| abstract_inverted_index.70, | 225 |
| abstract_inverted_index.75, | 211 |
| abstract_inverted_index.95% | 367, 397, 404 |
| abstract_inverted_index.966 | 288 |
| abstract_inverted_index.AF. | 87, 453 |
| abstract_inverted_index.Age | 199 |
| abstract_inverted_index.Cox | 352 |
| abstract_inverted_index.IQR | 226, 275, 280 |
| abstract_inverted_index.The | 39, 89, 229 |
| abstract_inverted_index.and | 24, 85, 105, 108, 125, 132, 149, 155, 161, 168, 187, 243, 400, 425, 451 |
| abstract_inverted_index.for | 17, 417, 439 |
| abstract_inverted_index.had | 193 |
| abstract_inverted_index.has | 43 |
| abstract_inverted_index.may | 433 |
| abstract_inverted_index.the | 7, 15, 21, 55, 72, 76, 97, 188, 204, 218, 259, 267, 307, 315, 334, 342 |
| abstract_inverted_index.vs. | 277, 322 |
| abstract_inverted_index.was | 94, 200, 234, 255, 287, 428 |
| abstract_inverted_index.(27% | 321 |
| abstract_inverted_index.(59% | 249 |
| abstract_inverted_index.(AF) | 70 |
| abstract_inverted_index.15%, | 323 |
| abstract_inverted_index.41%, | 251 |
| abstract_inverted_index.CLTI | 52, 111, 123, 445 |
| abstract_inverted_index.CTLI | 82 |
| abstract_inverted_index.This | 117 |
| abstract_inverted_index.WIfI | 40, 102, 129, 144, 162, 182, 194, 205, 219, 238, 260, 268, 308, 316, 335, 343, 359, 391, 420 |
| abstract_inverted_index.been | 44 |
| abstract_inverted_index.days | 289 |
| abstract_inverted_index.died | 296 |
| abstract_inverted_index.foot | 25 |
| abstract_inverted_index.from | 387 |
| abstract_inverted_index.have | 47 |
| abstract_inverted_index.rate | 230, 332 |
| abstract_inverted_index.than | 35, 265, 313, 340 |
| abstract_inverted_index.that | 358 |
| abstract_inverted_index.then | 136 |
| abstract_inverted_index.this | 92 |
| abstract_inverted_index.well | 59 |
| abstract_inverted_index.were | 304, 377, 407 |
| abstract_inverted_index.with | 84, 217, 410, 450 |
| abstract_inverted_index.(20%) | 295 |
| abstract_inverted_index.(38%) | 192 |
| abstract_inverted_index.(62%) | 180 |
| abstract_inverted_index.(IQR) | 214 |
| abstract_inverted_index.(IQR, | 290 |
| abstract_inverted_index.2–3 | 276 |
| abstract_inverted_index.Among | 175 |
| abstract_inverted_index.Forty | 293 |
| abstract_inverted_index.While | 54 |
| abstract_inverted_index.after | 139, 297 |
| abstract_inverted_index.death | 303, 443 |
| abstract_inverted_index.group | 148, 167, 209, 223, 242, 248, 264, 272, 312, 320, 339, 347, 363, 395, 424 |
| abstract_inverted_index.known | 60 |
| abstract_inverted_index.lower | 330 |
| abstract_inverted_index.range | 213 |
| abstract_inverted_index.ratio | 365 |
| abstract_inverted_index.score | 57, 78, 254, 373, 402, 427, 432 |
| abstract_inverted_index.stage | 42, 104, 131, 145, 151, 164, 170, 183, 195, 206, 220, 239, 245, 261, 269, 309, 317, 336, 344, 360, 392, 421 |
| abstract_inverted_index.study | 93, 119 |
| abstract_inverted_index.using | 384 |
| abstract_inverted_index.value | 50 |
| abstract_inverted_index.(CLTI) | 5 |
| abstract_inverted_index.(WIfI) | 27 |
| abstract_inverted_index.1–2, | 281 |
| abstract_inverted_index.CHADS2 | 56, 77, 106, 133, 253, 372, 401, 426, 431 |
| abstract_inverted_index.Median | 283 |
| abstract_inverted_index.Wound, | 22 |
| abstract_inverted_index.artery | 12 |
| abstract_inverted_index.atrial | 68 |
| abstract_inverted_index.attack | 66 |
| abstract_inverted_index.days). | 292 |
| abstract_inverted_index.death. | 381, 412 |
| abstract_inverted_index.group, | 154 |
| abstract_inverted_index.group. | 173 |
| abstract_inverted_index.hazard | 354 |
| abstract_inverted_index.higher | 202, 257, 305 |
| abstract_inverted_index.lesion | 37 |
| abstract_inverted_index.median | 278 |
| abstract_inverted_index.rather | 34 |
| abstract_inverted_index.score, | 107 |
| abstract_inverted_index.score. | 134 |
| abstract_inverted_index.showed | 181, 327, 390 |
| abstract_inverted_index.test). | 351 |
| abstract_inverted_index.(median | 224, 273 |
| abstract_inverted_index.Chronic | 2 |
| abstract_inverted_index.Methods | 116 |
| abstract_inverted_index.P-value | 416 |
| abstract_inverted_index.Purpose | 88 |
| abstract_inverted_index.Results | 174 |
| abstract_inverted_index.Society | 16 |
| abstract_inverted_index.Surgery | 19 |
| abstract_inverted_index.[Hazard | 364 |
| abstract_inverted_index.[median | 210 |
| abstract_inverted_index.between | 142, 158, 237 |
| abstract_inverted_index.crucial | 436 |
| abstract_inverted_index.disease | 32 |
| abstract_inverted_index.factors | 100, 386 |
| abstract_inverted_index.p=0.17. | 429 |
| abstract_inverted_index.purpose | 90 |
| abstract_inverted_index.remains | 79 |
| abstract_inverted_index.system, | 29 |
| abstract_inverted_index.thought | 45 |
| abstract_inverted_index.unclear | 80 |
| abstract_inverted_index.without | 86, 452 |
| abstract_inverted_index.(p=0.002 | 348 |
| abstract_inverted_index.63–79, | 227 |
| abstract_inverted_index.68–82] | 215 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.Vascular | 18 |
| abstract_inverted_index.analysis | 326, 356, 383, 389 |
| abstract_inverted_index.arterial | 36 |
| abstract_inverted_index.assessed | 128 |
| abstract_inverted_index.baseline | 159 |
| abstract_inverted_index.clinical | 41, 73, 99, 103, 130, 163 |
| abstract_inverted_index.compared | 137, 216 |
| abstract_inverted_index.disease. | 13 |
| abstract_inverted_index.duration | 284 |
| abstract_inverted_index.focusing | 30 |
| abstract_inverted_index.interval | 369 |
| abstract_inverted_index.ischemia | 4 |
| abstract_inverted_index.ischemic | 63, 65 |
| abstract_inverted_index.log-rank | 350 |
| abstract_inverted_index.p=0.008) | 376 |
| abstract_inverted_index.p=0.019) | 406 |
| abstract_inverted_index.p=0.031) | 399 |
| abstract_inverted_index.p=0.84). | 252 |
| abstract_inverted_index.patients | 83, 112, 124, 179, 191, 233, 294, 446 |
| abstract_inverted_index.predicts | 62 |
| abstract_inverted_index.relevant | 385 |
| abstract_inverted_index.revealed | 357 |
| abstract_inverted_index.severity | 33 |
| abstract_inverted_index.survival | 331 |
| abstract_inverted_index.(HR:1.34, | 403 |
| abstract_inverted_index.(HR;1.42, | 374 |
| abstract_inverted_index.(HR;2.18, | 396 |
| abstract_inverted_index.Infection | 26 |
| abstract_inverted_index.Ischemia, | 23 |
| abstract_inverted_index.Recently, | 14 |
| abstract_inverted_index.all-cause | 302, 380, 411, 442 |
| abstract_inverted_index.end-stage | 8 |
| abstract_inverted_index.follow-up | 286 |
| abstract_inverted_index.incidence | 440 |
| abstract_inverted_index.including | 101 |
| abstract_inverted_index.mortality | 109, 138 |
| abstract_inverted_index.p=0.003], | 371 |
| abstract_inverted_index.p=0.004). | 228 |
| abstract_inverted_index.p=0.013). | 282 |
| abstract_inverted_index.p=0.047). | 324 |
| abstract_inverted_index.patients, | 71, 177 |
| abstract_inverted_index.patients. | 53 |
| abstract_inverted_index.predictor | 438 |
| abstract_inverted_index.remaining | 189 |
| abstract_inverted_index.(HR);2.62, | 366 |
| abstract_inverted_index.540–1268 | 291 |
| abstract_inverted_index.Background | 1 |
| abstract_inverted_index.Conclusion | 430 |
| abstract_inverted_index.Incidences | 300 |
| abstract_inverted_index.associated | 409 |
| abstract_inverted_index.comparison | 414 |
| abstract_inverted_index.confidence | 368 |
| abstract_inverted_index.correlated | 378 |
| abstract_inverted_index.difference | 236 |
| abstract_inverted_index.peripheral | 11 |
| abstract_inverted_index.prognostic | 49 |
| abstract_inverted_index.represents | 6 |
| abstract_inverted_index.undergoing | 113, 447 |
| abstract_inverted_index.univariate | 355, 388 |
| abstract_inverted_index.association | 157 |
| abstract_inverted_index.consecutive | 122 |
| abstract_inverted_index.established | 20 |
| abstract_inverted_index.independent | 437 |
| abstract_inverted_index.interaction | 418 |
| abstract_inverted_index.investigate | 96 |
| abstract_inverted_index.patient’s | 98 |
| abstract_inverted_index.Multivariate | 382 |
| abstract_inverted_index.endovascular | 114, 140, 298, 448 |
| abstract_inverted_index.fibrillation | 69 |
| abstract_inverted_index.individually | 127 |
| abstract_inverted_index.intervention | 141, 449 |
| abstract_inverted_index.investigated | 120, 156 |
| abstract_inverted_index.proportional | 353 |
| abstract_inverted_index.significance | 74 |
| abstract_inverted_index.interquartile | 212 |
| abstract_inverted_index.intervention. | 115, 299 |
| abstract_inverted_index.manifestation | 9 |
| abstract_inverted_index.retrospective | 118 |
| abstract_inverted_index.significantly | 201, 256, 329, 408 |
| abstract_inverted_index.Kaplan–Meier | 325 |
| abstract_inverted_index.classification | 28 |
| abstract_inverted_index.CI:1.02–1.73, | 405 |
| abstract_inverted_index.CI:1.04–4.16, | 398 |
| abstract_inverted_index.characteristics | 160 |
| abstract_inverted_index.characteristics. | 38 |
| abstract_inverted_index.limb-threatening | 3 |
| abstract_inverted_index.stroke/transient | 64 |
| abstract_inverted_index.(CI):1.39–4.91, | 370 |
| abstract_inverted_index.95%CI:1.08–1.82, | 375 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 6 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.800000011920929 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.37225581 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |